Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Bennett

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2013
Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemiaAdam W Mailloux, Ling Zhang, Lynn Moscinski, et al.
Cancer|July 2, 2003
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology GroupArthur I Radin, Haesook T Kim, Barbara W Grant, et al.
Cancers|April 26, 2025
Association Between B-Cell Marker Expression and <i>RUNX1</i> Lesions in Acute Myeloid Leukemia, Beyond <i>RUNX1</i>::<i>RUNX1T1</i> Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/MyeloidGiby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
Acta Haematologica|November 22, 2014
A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institutionDeniz Peker, Eric Padron, John M Bennett, et al.
Ejhaem|September 2, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasmsSiba El Hussein, Mariko Yabe, Wei Wang, et al.
Blood|September 27, 2003
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology GroupJacob M Rowe, Donna Neuberg, William Friedenberg, et al.
Leukemia & Lymphoma|December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Leukemia & Lymphoma|December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Blood|July 1, 2009
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)Peter L Greenberg, Zhuoxin Sun, Kenneth B Miller, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2013
Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemiaAdam W Mailloux, Ling Zhang, Lynn Moscinski, et al.
Cancer|July 2, 2003
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology GroupArthur I Radin, Haesook T Kim, Barbara W Grant, et al.
Cancers|April 26, 2025
Association Between B-Cell Marker Expression and <i>RUNX1</i> Lesions in Acute Myeloid Leukemia, Beyond <i>RUNX1</i>::<i>RUNX1T1</i> Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/MyeloidGiby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
Acta Haematologica|November 22, 2014
A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institutionDeniz Peker, Eric Padron, John M Bennett, et al.
Ejhaem|September 2, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasmsSiba El Hussein, Mariko Yabe, Wei Wang, et al.
Blood|September 27, 2003
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology GroupJacob M Rowe, Donna Neuberg, William Friedenberg, et al.
Leukemia & Lymphoma|December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Leukemia & Lymphoma|December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Blood|July 1, 2009
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)Peter L Greenberg, Zhuoxin Sun, Kenneth B Miller, et al.
Pageof 17